VVV
Valion Bio, Inc.
No trades
No trades
Compare with Valion Bio, Inc.
−8.76 M USD
0.00 USD
885.82 K
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Dean Zikria
Website
Headquarters
San Antonio
Founded
2016
IPO date
Nov 11, 2021
ISIN
US9189422028
CUSIP
918942202
FIGI
BBG00PT2YC04
Identifiers
ISIN US9189422028
Valion Bio, Inc. operates as a bio-electronic health-tech company, which develops micro current therapy solutions for chronic diseases and conditions. The company was founded by Jennifer Ernst and John Claude on September 22, 2016 and is headquartered in San Antonio, TX.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of VBIO is 2.21 USD — it has increased by 0.91% in the past 24 hours. Watch Valion Bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Valion Bio, Inc. stocks are traded under the ticker VBIO.
VBIO stock has fallen by −13.33% compared to the previous week, the month change is a −19.34% fall, over the last year Valion Bio, Inc. has showed a −97.07% decrease.
VBIO reached its all-time high on Nov 11, 2021 with the price of 276,250.00 USD, and its all-time low was 2.05 USD and was reached on Sep 16, 2026. View more price dynamics on VBIO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
VBIO stock is 10.14% volatile and has beta coefficient of 2.18. Track Valion Bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is Valion Bio, Inc. there?
Today Valion Bio, Inc. has the market capitalization of 1.96 M, it has decreased by −15.00% over the last week.
Yes, you can track Valion Bio, Inc. financials in yearly and quarterly reports right on TradingView.
Valion Bio, Inc. is going to release the next earnings report on Nov 13, 2026. Keep track of upcoming events with our Earnings Calendar.
VBIO net income for the last quarter is −7.10 M USD, while the quarter before that showed −6.20 M USD of net income which accounts for 0.00% change. Track more Valion Bio, Inc. financial stats to get the full picture.
No, VBIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 9, 2026, the company has 52 employees. See our rating of the largest employees — is Valion Bio, Inc. on this list?
Like other stocks, VBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Valion Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Valion Bio, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Valion Bio, Inc. stock shows the sell signal. See more of Valion Bio, Inc. technicals for a more comprehensive analysis.